Novavax forecasts higher-than-expected revenue; shares surge
By Bhanvi Satija and Michael Erman (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday forecast much higher 2023 revenue than Wall Street expected and announced plans to cut a quarter of its workforce, spurring hopes of a recovery for the cash-strapped biotech, and its shares jumped 40%. In February, the company raised doubts about its…
